[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100183383":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":20,"locations":30,"responsibleParty":48,"collaborators":10,"id":50,"slug":51,"hasResults":52,"nctId":53,"briefTitle":54,"officialTitle":55,"acronym":56,"eligibilityCriteria":57,"healthyVolunteers":58,"sex":59,"minAge":10,"maxAge":10,"enrollmentInfo":60,"targetDuration":10,"studyType":63,"phases":10,"briefSummary":64,"conditions":65,"keywords":66,"overallStatus":33,"whyStopped":10,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"NYU Langone Health","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"SUDEP Group",null,"The SUDEP group refers to epileptic patients that had a sudden unexplained death; excludes trauma, drowning, status epilepticus, or other known cause, but there is often evidence of an associated seizure.",{"label":13,"type":10,"description":14,"interventionNames":10},"Control Group","We will recruit living patients with epilepsy for the control group. In particular, epileptic patients with Dravet Syndrome of Idic 15.",[16],{"name":17,"affiliation":18,"role":19},"Orrin Devinsky, MD","NYU School of Medicine","PRINCIPAL_INVESTIGATOR",[21,26],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Abigail Laze","CONTACT","646-558-0835","Juliana.laze@nyulangone.org",{"name":27,"role":23,"phone":28,"phoneExt":10,"email":29},"Abigail Straight","646-558-0848","Abigail.straight@nyulangone.org",[31],{"facility":32,"status":33,"city":34,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"NYU Comprehensive Epilepsy Center","RECRUITING","New York","10016","United States","US",{"type":39,"coordinates":40},"Point",[41,42],-74.00597,40.71427,{"lat":42,"lon":41},[45,47],{"name":46,"role":23,"phone":24,"phoneExt":10,"email":25},"Juliana Laze",{"name":17,"role":19,"phone":10,"phoneExt":10,"email":10},{"type":49,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100183383","risk-factors-for-sudden-unexplained-death-in-epilepsy-100183383",false,"NCT01662453","Risk Factors for Sudden Unexplained Death in Epilepsy","Risk Factors for Sudden Unexplained Death in Epilepsy (SUDEP)","SUDEP","Inclusion Criteria Sudep Group Subjects diagnosed with epilepsy whose cause of death was sudden and unexplained, and whose families are willing to participate, will be included in the study.\n\nControl Group For the control group, we will include any patient diagnosed with epilepsy currently in the care of the NYU Comprehensive Epilepsy Center, willing and able to participate in the study.",true,"ALL",{"count":61,"type":62},800,"ESTIMATED","OBSERVATIONAL","The main purpose of this study is to develop a North American registry for SUDEP cases; requesting family members of epilepsy patients who died suddenly of unclear causes (SUDEP) to contact the study team. The family members who decide to participate in the study will be asked to complete a brief telephone interview about their loved one's epilepsy and seizure history and the circumstances of his or her death. If the death has occurred within the past 24 hours, and the family is willing to consider donating tissue to the study, the subject will be transferred to the Autism Tissue Program, and the remainder of the phone interview will be conducted at a later time.\n\nIn addition to the phone interview, the family will be asked to provide access to the deceased's medical records. Any costs involved in obtaining medical records will be covered by the study, and all medical information will remain completely confidential.",[56],[67,68,69,70,71],"epilepsy","seizures","mortality","sudep","risk factors","2026-06-03",{"date":74,"type":75},"2026-06-04","ACTUAL",{"date":77,"type":10},"2011-06",{"date":79,"type":62},"2027-09",{"name":5,"class":6},1]